Series: Chasms of Evolutionary Impossibilities – Douglas Axe’s Work (2004) and the Evolutionary Impossibility of a Mere Protein.
doi:10.1016/j.jmb.2004.06.058
7.3 “Cherry-Picking of Problematic Protein”
When the standard model bothers, they call it biased selection
Objection
Some critics claim that Douglas Axe chose the β-lactamase protein in a biased manner — as if "hand-picking" data that favors his hypothesis. The accusation is that he ignored more neutral or representative proteins and opted for one he knew would yield results unfavorable to evolution.
🪜 For the lay reader: It is like accusing a meteorologist of manipulating the weather forecast because you didn't like that it rained on your picnic day. The rain happened — the problem isn't the forecast, it's the fact.
What Axe Actually Did
Axe followed objective and widely recognized criteria to choose β-lactamase as an experimental model. According to Section 2.1 of the original article, the choice was based on five factors:
- Easy-to-measure function: The protein breaks down antibiotics. If the bacteria survive, the protein works. If they die, it doesn't. Simple as that.
- Known structure: β-lactamase has a complete "3D map" — like knowing every part of an engine.
- Reliable testing system: The experiment uses bacteria as living sensors. It's easy to see who lives and who dies.
- Ideal size: Neither too big nor too small — perfect for laboratory manipulation.
- Usage history: The scientific community has used this protein for decades. The study by Reidhaar-Olson & Sauer (1990) used exactly the same protein and was celebrated as exemplary.
🪜 Analogy:
Where is the Logical Error?
The criticism commits the straw man fallacy — it creates a caricature of the study, as if Axe had chosen an obscure and manipulable protein. In reality, he used the most popular and validated protein for this type of study.
🪜 Analogy:
What the Data Show
β-lactamase is used in more than 214 scientific studies on protein evolution. It is the "Honda Civic" of proteins: reliable, accessible, easy to measure, and widely tested.
🪜 For the lay reader: Imagine you need to test which car is safer in collisions. Would you choose:
- a) A rare Ferrari that nobody knows
- b) A Honda Civic that everyone uses in tests
Axe did the obvious: he chose the Honda Civic of proteins. The critics wanted him to have chosen the Ferrari — but that would be bad science.
Model
If we applied a scoring system to choose the ideal model for evolvability tests, β-lactamase would have:
Criterion | Score |
---|---|
Functional safety | 10/10 |
Experimental cost | 10/10 |
Ease of measurement | 9/10 |
Structural size | 8/10 |
🪜 Functional analogy:
What Does the Scientific Literature Say?
- Reidhaar-Olson & Sauer (1990): Used the same protein and were widely cited as a methodological reference
- Protein Database: Shows over 200 studies using β-lactamase as an evolutionary model
- Biochemistry Manuals: Recommend this protein for mutation and function studies
🪜 For the lay reader: This data shows that Axe did not "hand-pick" — he followed the science manual.
Why This Criticism Fails
The criticism reveals a paradigmatic anomaly:
- When β-lactamase produces results favorable to evolution → "Valid model! Excellent choice!"
- When it produces unfavorable results → "Cherry-picking! Problematic protein!"
🪜 Final analogy:
Conclusion for the Lay Reader
The cherry-picking accusation does not hold. Axe used the standard protein, with objective criteria recognized by the scientific community.
🪜 Visual summary:
Therefore, this criticism does not invalidate the study.
Priority Self-Refuting Sources (κ > 0.9)
- Reidhaar-Olson & Sauer (1990): Validate the use of β-lactamase as an evolutionary model
- Protein Database: Confirms over 200 studies with the same protein
- Biochemistry Manuals: Recommend β-lactamase for mutation and function studies